Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

British Journal of Pharmacology

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • B-1 and B-2 kinin receptor blockade improves psoriasis-like disease 2020
  • NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area 2020
  • Lasting effects of repeated ∆9 -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats 2020
  • The BJP expects authors to share data.  176:4595-4598. 2019
  • Sex differences in mouse models of fear inhibition: Fear extinction, safety learning, and fear-safety discrimination.  176:4149-4158. 2019
  • Sex: A change in our guidelines to authors to ensure that this is no longer an ignored experimental variable 2019
  • Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats.  176:1524-1540. 2019
  • A novel inhibitor of inducible NOS dimerization protects against cytokine-induced rat beta cell dysfunction.  175:3470-3485. 2018
  • Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers.  175:987-993. 2018
  • Robust anti-nociceptive effects of monoacylglycerol lipase inhibition in a model of osteoarthritis pain.  173:3134-3144. 2016
  • Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P(1)) and receptor-5 (S1P(5)) agonist with autoimmune disease-modifying activity.  173:1778-1792. 2016
  • Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain.  173:1678-1692. 2016
  • Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo.  173:1438-1451. 2016
  • Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9)-tetrahydrocannabinol in Sprague-Dawley rats.  172:1783-1791. 2015
  • AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation.  172:1292-1304. 2015
  • Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.  172:869-882. 2015
  • Lysophospholipid receptor nomenclature review: IUPHAR Review 8.  171:3575-3594. 2014
  • In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.  171:1392-1407. 2014
  • Functional pharmacology of H-1 histamine receptors expressed in mouse preoptic/anterior hypothalamic neurons.  170:415-425. 2013
  • A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects.  169:784-793. 2013
  • Cannabidiol attenuates deficits of visuo-spatial associative memory induced by Δ9 tetrahydrocannabinol 2013
  • β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.  166:1474-1489. 2012
  • Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats.  165:2425-2435. 2012
  • The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.  165:2485-2496. 2012
  • Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.  165:1556-1571. 2012
  • Insights into the pharmacological relevance of lysophospholipid receptors.  165:829-844. 2012
  • Mephedrone (4-methylmethcathinone) and d-methamphetamine improve visuospatial associative memory, but not spatial working memory, in rhesus macaques.  167:1342-1352. 2012
  • Systemic urocortin 2, but not urocortin 1 or stressin1-a, suppresses feeding via crf2 receptors without malaise and stress.  164:1959-1975. 2011
  • Cox-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation.  164:1672-1683. 2011
  • Reviewer comments on Reflections on drug research by Sir James Black.  161:1217-1217. 2010
  • Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.  160:549-560. 2010
  • Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.  160:423-442. 2010
  • The phospholipase A(2) inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice.  157:1263-1269. 2009
  • Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools.  153:140-147. 2008
  • Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cells.  142:150-160. 2004
  • Evidence in locomotion test for the functional heterogeneity of orl-1 receptors.  141:132-140. 2004
  • Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.  141:241-252. 2004
  • Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor.  139:575-584. 2003
  • Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.  139:109-121. 2003
  • Nociceptin (1-7) antagonizes nociceptin-induced hyperalgesia in mice.  128:941-944. 1999
  • Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells.  128:613-620. 1999
  • Antagonistic action of pitrazepin on human and rat gaba(a) receptors.  127:57-64. 1999
  • The role of alpha(2)-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat.  124:1550-1556. 1998
  • The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.  124:889-896. 1998
  • Identification and pharmacological characterization of somatostatin receptors in rat lung.  121:963-971. 1997
  • New high affinity peptide antagonists to the spinal galanin receptor.  116:2076-2080. 1995
  • Functional-effects of long-term activation on human beta(2)-adrenoceptor and beta(3)-adrenoceptor signaling.  114:1045-1051. 1995
  • Mediation of most atypical effects by species homologs of the beta(3)-adrenoceptor.  112:911-919. 1994
  • Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.  111:1129-1134. 1994
  • Evidence for a functional beta(3)-adrenoceptor in man.  110:929-936. 1993
  • Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.  103:1719-1724. 1991
  • Responsiveness of platelets and coronary-arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogs.  78:287-292. 1983
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0007-1188

Electronic International Standard Serial Number (EISSN)

  • 1476-5381

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support